Skip to main content

Table 1 Descriptions of Research Studies and Clinical Trials

From: Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows Program and the International AIDS Vaccine Initiative

Study

Description

Observational study

A study where researchers are learning about HIV/AIDS without actually testing a drug or other intervention. Such a study might involve drawing blood from trial participants over time, to understand characteristics of non-infected individuals and to observe what happens at the cellular level when they become infected.

Pre-clinical trials

Studies of vaccines or treatment which are carried out in animals.

Clinical trials

Phase I

Researchers test a vaccine in a small group of people (20–80) to determine how a drug should be given, how many doses are needed, and whether it is safe

Phase II

Experimental vaccine is given to a larger group of people (100–300) to see if it is effective and to further evaluate its safety

Phase III

Experimental vaccine is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, and compare to commonly used treatments.

Phase IV

Post-marketing studies determine a drug’s risks, benefits, and optimal use.

  1. Source: http://clinicaltrials.gov/ct2/info/understand.